Paracetamol Among Drugs Labelled ‘Not of Standard Quality’ by CDSCO

The Central Drugs Standards Control Organisation (CDSCO) has raised concerns regarding the quality of Paracetamol, a common medication used to treat fevers, along with 52 other drugs, after labeling them as ‘not of standard quality’ (NSQ). This announcement comes as part of the CDSCO’s routine quality check exercises conducted randomly by state drug officers across India.

Paracetamol has been a staple in households for treating fevers in particular, often referred to as a ‘no-brainer’ choice for generations. However, the recent NSQ alert published by the CDSCO mandates a reconsideration by those relying on this medication, highlighting the importance of quality assurance in pharmaceutical consumption.

Experts suggest alternatives for those uncertain about continuing with Paracetamol while the alert is in place. Dr. Minesh Mehta, a Consultant Intensive and Critical Care Specialist at Ahmedabad’s Shalby Hospital, recommends alternatives such as Ibuprofen, Meprocin, Meftal, Diclofenac, and Nimesulide. Additionally, Dr. Vibhu Kawatra, a Pediatric Pulmonologist at Delhi’s Rainbow Hospital, outlines several natural remedies to assist in easing symptoms of fever and improving recovery.

“Drinking plenty of fluids such as water, herbal teas, and clear broths aids in hydration and can help in cooling the body,” Dr. Kawatra explains. He also suggests the use of ginger or peppermint tea for its soothing effects, as well as willow bark and turmeric for their analgesic and anti-inflammatory properties respectively.

The NSQ alert also includes other drugs like vitamin C and D3 tablets, Shelcal, vitamin B complex, vitamin C soft gels, Pan-D, Glimepiride, and Telmisartan. These drugs have been cited in the list following various assessment failures like improper dissolution or incorrect labeling. The monthly reports serve to inform stakeholders and ensure pharmaceutical companies uphold high-quality standards.

The classification of NSQ drugs by regulators often includes three categories: Spurious drugs that imitate other brands, NSQ drugs that fail due to incorrect formulations or dilution, and adulterated drugs containing harmful contaminants. While these alerts are primarily for regulatory action, consumers are advised to consult healthcare providers before altering prescribed medication routines.

These efforts ensure public health safety by nudging companies towards maintaining impeccable standards in drug production. The CDSCO insists that its alerts are not intended to incite panic but to empower informed decisions for safe pharmaceutical practices. Consumers are encouraged to consult medical practitioners regarding the continuation or substitution of their medications in light of these warnings.